Why is BCAX Down Today?
About Bicara Therapeutics Inc. Common Stock
Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, dir...
Overall Confidence: 60%
Based on news, social sentiment, options activity, and sector analysis
✅ Move Confirmation
UNCONFIRMED - Low volume suggests this move may not be sustainable.
📍 Sector Context
PHARMACEUTICAL PREPARATIONS sector: -0.6%
Market Comparison
Quick Trade Ideas
Options strategies to consider for BCAX's -6% move
No Options Available
BCAX doesn't have listed options or options data is currently unavailable.
Try another stock in our Options Calculator →🔔 Get BCAX Alerts
We'll notify you when BCAX's trend changes or a new signal fires.
Data refreshes every 30 minutes during market hours
Historical Context
BCAX has moved more than 3.0% down on 38 occasions in the past year.
Frequently Asked Questions
Why is BCAX stock down today?
This stock is significantly underperforming its PHARMACEUTICAL PREPARATIONS sector peers, suggesting a stock-specific catalyst.
Is BCAX stock a buy or sell right now?
Based on current analysis, BCAX shows 60% confidence in today's move. Volume is low which does not confirm the trend. View full buy/sell analysis →
What is the BCAX stock price target?
BCAX is currently trading at $9.94. Based on today's momentum, the expected short-term range is $9.64 - $10.14. See long-term price prediction →
Will BCAX stock continue falling?
Our analysis shows a 45% probability that BCAX's move continues in the next 1-3 days. Key level to watch: $9.44 (support).
Is BCAX stock oversold or overbought?
BCAX's RSI (Relative Strength Index) is currently at 34.5. This shows bearish momentum - the stock has negative momentum but isn't oversold yet.
What is the momentum for BCAX stock?
BCAX's 10-day momentum indicator is at 0.38. Positive momentum - the stock has mild upward pressure supporting the current trend.
Is BCAX outperforming or underperforming the market?
BCAX (-5.60%) is currently significantly underperforming the market (-5.2% vs SPY). Today, the S&P 500 (SPY) is down -0.35%, and Nasdaq (QQQ) is down -0.32%.
What does MACD indicate for BCAX?
BCAX's MACD (-2.37) is currently above the signal line (-2.5), indicating a bullish trend. This technical signal suggests buying pressure is dominant. The trend strength (ADX: 50.6) is strong.
Is BCAX in an uptrend or downtrend?
Based on moving average analysis, BCAX is in a bearish trend. The price ($9.94) is trading below both the 20-day SMA ($12.58) and 50-day SMA ($17.1). This alignment typically indicates sustained downward pressure.
Check Why Another Stock is Moving
Enter any ticker symbol to see real-time analysis